riltrava aerosphere
astrazeneca ab - budesonide, formoterol fumarate dihydrate, glycopyrronium bromide - Πνευμονική Νόσος, Χρόνια Αποφρακτική - Φάρμακα αποφρακτικών παθήσεων των αναπνευστικών οδών, - riltrava aerosphere is indicated as a maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long-acting beta2 agonist or combination of a long-acting beta2 agonist and a long-acting muscarinic antagonist (for effects on symptoms control and prevention of exacerbations see section 5.
phenergan 25mg/1ml injection
sanofi-aventis cyprus ltd - Η ΠΡΟΜΕΘΑΖΊΝΗ ΥΔΡΟΧΛΩΡΙΚΉ - injection - 25mg/1ml - 0000058333 - promethazine hydrochloride - 25 mg - promethazine
efenax 0.1%de.ph+0.5%+0.12% nas.spr
pharmall eebe - phenylephrine hydrochloride - ΕΚΝΕΦΩΜΑ ΡΙΝΙΚΟ - 0.1%de.ph+0.5%+0.12% - ΦΑΡΜΑΚΕΥΤΙΚΟ ΠΡΟΪΟΝ
phenergan 2% cream
sanofi-aventis aebe - promethazine - ΚΡΕΜΑ - 2% - ΦΑΡΜΑΚΕΥΤΙΚΟ ΠΡΟΪΟΝ
vibrocil-s nasal drops
glaxosmithkline ΚΑΤΑΝΑΛΩΤΙΚΑ ΠΡΟΙΟΝΤΑ ΥΓΕΙΑΣ ΕΛΛΑΣ ΜΟΝΟΠΡΟΣΩΠΗ ΑΝΩΝΥΜΗ ΕΤΑΙΡΕΙΑ (gsk ch ΕΛΛΑΣ ΜΟΝΟΠΡΟΣΩΠΗ Α.Ε.) (0000011419) 274 - dimetindene maleate; phenylephrine - nasal drops - dimetindene maleate (0003614695) 0.025% w/v; phenylephrine (0000059427) 0.25% w/v - phenylephrine
panadol cold & flu & cough 1000mg/200mg/12.2mg powder for oral solution
glaxosmithkline ΚΑΤΑΝΑΛΩΤΙΚΑ ΠΡΟΙΟΝΤΑ ΥΓΕΙΑΣ ΕΛΛΑΣ ΑΝΩΝΥΜΗ ΕΤΑΙΡΕΙΑ (gsk ch ΕΛΛΑΣ ΑΕ) (0000008378) 274 kifisias ave, athens, 152 32 - paracetamol; guaifenesin; phenylephrine hydrochloride - powder for oral solution - 1000mg/200mg/12.2mg - paracetamol (0000103902) 1000mg; guaifenesin (0000093141) 200mg; phenylephrine hydrochloride (0000061767) 12,2mg - paracetamol, combinations excl psycholeptics
prothromplex total ps.inj.sol 600 iu/20ml
baxalta innovations gmbh, austria industriestrasse 67, a-1221 vienna +43 1 20 100-0 - factor ii (prothrombin); factor vii (proconvertin); factor ix (monoclonal antibody purified); factor x (stuart prower factor); human protein c - ps.inj.sol (ΚΟΝΙΣ ΚΑΙ ΔΙΑΛΥΤΗΣ ΓΙΑ ΕΝΕΣΙΜΟ ΔΙΑΛΥΜΑ) - 600 iu/20ml - factor ii (prothrombin) 480 - 850iu; factor vii (proconvertin) 500iu; factor ix (monoclonal antibody purified) 600iu; factor x (stuart prower factor) 600iu; human protein c 400iu - coagulation factor ix, ii, vii and x in combination
tektrotyde 16mcg/vial (kit) λυοφιλοποιημενο υλικο για ενεσιμο διαλυμα
Γ.ΠΑΠΑΝΙΚΟΛΟΣ-Α.ΜΠΟΥΜΠΑΣ Ο.Ε. Δ.Τ. mediray (ΜΕΝΤΙΡΕΪ) (0000009331) Λεωφόρος Μεσογείων 224 & Αετιδέων 2, Χολαργός, 155 61 - hynic-[d-phel1,tyr3-octreotide]-tfa - ΛΥΟΦΙΛΟΠΟΙΗΜΕΝΟ ΥΛΙΚΟ ΓΙΑ ΕΝΕΣΙΜΟ ΔΙΑΛΥΜΑ - 16mcg/vial (kit) - ineof02282 hynic-[d-phel1,tyr3-octreotide]-tfa 16.000000 mcg - technetium (99mtc) compounds
tektrotyd® rad.pha.kt 20mcg/vial
narodowe centrum badaŃ jĄdrowych (the national center for nuclear research), poland ul. andrzeja sołtana 7, 05-400 otwock 0048 22 718 0700 - hynic-[d-phel1,tyr3-octreotide]-tfa - rad.pha.kt (ΤΥΠΟΠΟΙΗΜΕΝΗ ΣΥΣΚΕΥΑΣΙΑ ΓΙΑ ΡΑΔΙΟΦΑΡΜΑΚΕΥΤΙΚΟ ΣΚΕΥΑΣΜΑ) - 20mcg/vial - hynic-[d-phel1,tyr3-octreotide]-tfa 20mcg - technetium (99mtc) hynic-octreotide
nephrotect sol.inf 10%
fresenius kabi hellas ae Λεωφ. Κηφισίας 64Α, 151 25 Μαρούσι Αττικής 6542909 - isoleucine; leucine; lysine acetate; l-methionine; acetylcysteine; phenylalanine; threonine; tryptophan, l-; valine; arginine; histidine; glycine; alanine; proline; l-serine; tyrosine; glycyl-tyrosin (dipeptid) - sol.inf (ΔΙΑΛΥΜΑ ΓΙΑ ΕΓΧΥΣΗ) - 10% - isoleucine 5,8g; leucine 12,8g; lysine acetate 16,9g; l-methionine 2g; acetylcysteine 0,54g; phenylalanine 3,5g; threonine 8,2g; tryptophan, l- 3g; valine 8,7g; arginine 8,2g; histidine 9,8g; glycine 5,31g; alanine 6,2g; proline 3g; l-serine 7,6g; tyrosine 0,6g; glycyl-tyrosin (dipeptid) 3,16g - amino acids